Type 1 Gaucher disease (CYP2D6-eliglustat)
Autor*in: |
Becquemont, Laurent [verfasserIn] |
---|
Format: |
Artikel |
---|---|
Sprache: |
Französisch |
Erschienen: |
2017 |
---|
Übergeordnetes Werk: |
Enthalten in: Thérapie - Issy-les-Moulineaux : Elsevier, 1946, (2017) |
---|---|
Übergeordnetes Werk: |
year:2017 |
Links: |
---|
DOI / URN: |
10.1016/j.therap.2016.09.019 |
---|
Katalog-ID: |
OLC1990125069 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1990125069 | ||
003 | DE-627 | ||
005 | 20230715031028.0 | ||
007 | tu | ||
008 | 170303s2017 xx ||||| 00| ||fre c | ||
024 | 7 | |a 10.1016/j.therap.2016.09.019 |2 doi | |
028 | 5 | 2 | |a PQ20170301 |
035 | |a (DE-627)OLC1990125069 | ||
035 | |a (DE-599)GBVOLC1990125069 | ||
035 | |a (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190 | ||
035 | |a (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
082 | 0 | 4 | |a 610 |q DE-600 |
100 | 1 | |a Becquemont, Laurent |e verfasserin |4 aut | |
245 | 1 | 0 | |a Type 1 Gaucher disease (CYP2D6-eliglustat) |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
773 | 0 | 8 | |i Enthalten in |t Thérapie |d Issy-les-Moulineaux : Elsevier, 1946 |g (2017) |w (DE-627)130397423 |w (DE-600)603474-3 |w (DE-576)015900436 |x 0040-5957 |7 nnns |
773 | 1 | 8 | |g year:2017 |
856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.therap.2016.09.019 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-FRK | ||
912 | |a SSG-OLC-ROK | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_4219 | ||
951 | |a AR | ||
952 | |j 2017 |
author_variant |
l b lb |
---|---|
matchkey_str |
article:00405957:2017----::yeguhriescpd |
hierarchy_sort_str |
2017 |
publishDate |
2017 |
allfields |
10.1016/j.therap.2016.09.019 doi PQ20170301 (DE-627)OLC1990125069 (DE-599)GBVOLC1990125069 (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190 (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat DE-627 ger DE-627 rakwb fre 610 DE-600 Becquemont, Laurent verfasserin aut Type 1 Gaucher disease (CYP2D6-eliglustat) 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Enthalten in Thérapie Issy-les-Moulineaux : Elsevier, 1946 (2017) (DE-627)130397423 (DE-600)603474-3 (DE-576)015900436 0040-5957 nnns year:2017 http://dx.doi.org/10.1016/j.therap.2016.09.019 Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-FRK SSG-OLC-ROK SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_4219 AR 2017 |
spelling |
10.1016/j.therap.2016.09.019 doi PQ20170301 (DE-627)OLC1990125069 (DE-599)GBVOLC1990125069 (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190 (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat DE-627 ger DE-627 rakwb fre 610 DE-600 Becquemont, Laurent verfasserin aut Type 1 Gaucher disease (CYP2D6-eliglustat) 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Enthalten in Thérapie Issy-les-Moulineaux : Elsevier, 1946 (2017) (DE-627)130397423 (DE-600)603474-3 (DE-576)015900436 0040-5957 nnns year:2017 http://dx.doi.org/10.1016/j.therap.2016.09.019 Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-FRK SSG-OLC-ROK SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_4219 AR 2017 |
allfields_unstemmed |
10.1016/j.therap.2016.09.019 doi PQ20170301 (DE-627)OLC1990125069 (DE-599)GBVOLC1990125069 (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190 (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat DE-627 ger DE-627 rakwb fre 610 DE-600 Becquemont, Laurent verfasserin aut Type 1 Gaucher disease (CYP2D6-eliglustat) 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Enthalten in Thérapie Issy-les-Moulineaux : Elsevier, 1946 (2017) (DE-627)130397423 (DE-600)603474-3 (DE-576)015900436 0040-5957 nnns year:2017 http://dx.doi.org/10.1016/j.therap.2016.09.019 Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-FRK SSG-OLC-ROK SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_4219 AR 2017 |
allfieldsGer |
10.1016/j.therap.2016.09.019 doi PQ20170301 (DE-627)OLC1990125069 (DE-599)GBVOLC1990125069 (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190 (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat DE-627 ger DE-627 rakwb fre 610 DE-600 Becquemont, Laurent verfasserin aut Type 1 Gaucher disease (CYP2D6-eliglustat) 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Enthalten in Thérapie Issy-les-Moulineaux : Elsevier, 1946 (2017) (DE-627)130397423 (DE-600)603474-3 (DE-576)015900436 0040-5957 nnns year:2017 http://dx.doi.org/10.1016/j.therap.2016.09.019 Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-FRK SSG-OLC-ROK SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_4219 AR 2017 |
allfieldsSound |
10.1016/j.therap.2016.09.019 doi PQ20170301 (DE-627)OLC1990125069 (DE-599)GBVOLC1990125069 (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190 (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat DE-627 ger DE-627 rakwb fre 610 DE-600 Becquemont, Laurent verfasserin aut Type 1 Gaucher disease (CYP2D6-eliglustat) 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Enthalten in Thérapie Issy-les-Moulineaux : Elsevier, 1946 (2017) (DE-627)130397423 (DE-600)603474-3 (DE-576)015900436 0040-5957 nnns year:2017 http://dx.doi.org/10.1016/j.therap.2016.09.019 Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-FRK SSG-OLC-ROK SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_4219 AR 2017 |
language |
French |
source |
Enthalten in Thérapie (2017) year:2017 |
sourceStr |
Enthalten in Thérapie (2017) year:2017 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Thérapie |
authorswithroles_txt_mv |
Becquemont, Laurent @@aut@@ |
publishDateDaySort_date |
2017-01-01T00:00:00Z |
hierarchy_top_id |
130397423 |
dewey-sort |
3610 |
id |
OLC1990125069 |
language_de |
franzoesisch |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1990125069</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230715031028.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">170303s2017 xx ||||| 00| ||fre c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.therap.2016.09.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20170301</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1990125069</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1990125069</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)crossref_primary_10_1016_j_therap_2016_09_0190</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">fre</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Becquemont, Laurent</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Type 1 Gaucher disease (CYP2D6-eliglustat)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Thérapie</subfield><subfield code="d">Issy-les-Moulineaux : Elsevier, 1946</subfield><subfield code="g">(2017)</subfield><subfield code="w">(DE-627)130397423</subfield><subfield code="w">(DE-600)603474-3</subfield><subfield code="w">(DE-576)015900436</subfield><subfield code="x">0040-5957</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2017</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1016/j.therap.2016.09.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-FRK</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-ROK</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4219</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2017</subfield></datafield></record></collection>
|
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1990125069</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230715031028.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">170303s2017 xx ||||| 00| ||fre c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.therap.2016.09.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20170301</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1990125069</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1990125069</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)crossref_primary_10_1016_j_therap_2016_09_0190</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">fre</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Becquemont, Laurent</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Type 1 Gaucher disease (CYP2D6-eliglustat)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Thérapie</subfield><subfield code="d">Issy-les-Moulineaux : Elsevier, 1946</subfield><subfield code="g">(2017)</subfield><subfield code="w">(DE-627)130397423</subfield><subfield code="w">(DE-600)603474-3</subfield><subfield code="w">(DE-576)015900436</subfield><subfield code="x">0040-5957</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2017</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1016/j.therap.2016.09.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-FRK</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-ROK</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4219</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2017</subfield></datafield></record></collection>
|
author |
Becquemont, Laurent |
spellingShingle |
Becquemont, Laurent ddc 610 Type 1 Gaucher disease (CYP2D6-eliglustat) |
authorStr |
Becquemont, Laurent |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)130397423 |
format |
Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
OLC |
remote_str |
false |
illustrated |
Not Illustrated |
issn |
0040-5957 |
topic_title |
610 DE-600 Type 1 Gaucher disease (CYP2D6-eliglustat) |
topic |
ddc 610 |
topic_unstemmed |
ddc 610 |
topic_browse |
ddc 610 |
format_facet |
Aufsätze Gedruckte Aufsätze |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
nc |
hierarchy_parent_title |
Thérapie |
hierarchy_parent_id |
130397423 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Thérapie |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)130397423 (DE-600)603474-3 (DE-576)015900436 |
title |
Type 1 Gaucher disease (CYP2D6-eliglustat) |
ctrlnum |
(DE-627)OLC1990125069 (DE-599)GBVOLC1990125069 (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190 (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat |
title_full |
Type 1 Gaucher disease (CYP2D6-eliglustat) |
author_sort |
Becquemont, Laurent |
journal |
Thérapie |
journalStr |
Thérapie |
lang_code |
fre |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2017 |
contenttype_str_mv |
txt |
author_browse |
Becquemont, Laurent |
class |
610 DE-600 |
format_se |
Aufsätze |
author-letter |
Becquemont, Laurent |
doi_str_mv |
10.1016/j.therap.2016.09.019 |
dewey-full |
610 |
title_sort |
type 1 gaucher disease (cyp2d6-eliglustat) |
title_auth |
Type 1 Gaucher disease (CYP2D6-eliglustat) |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-FRK SSG-OLC-ROK SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_4219 |
title_short |
Type 1 Gaucher disease (CYP2D6-eliglustat) |
url |
http://dx.doi.org/10.1016/j.therap.2016.09.019 |
remote_bool |
false |
ppnlink |
130397423 |
mediatype_str_mv |
n |
isOA_txt |
false |
hochschulschrift_bool |
false |
doi_str |
10.1016/j.therap.2016.09.019 |
up_date |
2024-07-03T23:48:31.314Z |
_version_ |
1803603684956831744 |
score |
7.4000015 |